ValuEngine lowered shares of Edap Tms (NASDAQ:EDAP) from a buy rating to a hold rating in a research report released on Saturday, August 31st, ValuEngine reports.<\/p>\n
Other research analysts have also issued research reports about the stock. HC Wainwright set a $7.00 price target on shares of Edap Tms and gave the stock a buy rating in a research report on Tuesday, June 11th. TheStreet lowered shares of Edap Tms from a b- rating to a d+ rating in a report on Monday, June 17th. Finally, Zacks Investment Research raised shares of Edap Tms from a sell rating to a hold rating in a report on Tuesday, July 16th.<\/p>\n
Shares of EDAP traded up $0.08 during trading hours on Friday, reaching $4.08. 119,357 shares of the company traded hands, compared to its average volume of 109,650. Edap Tms has a 1-year low of $1.35 and a 1-year high of $5.42. The company has a debt-to-equity ratio of 0.09, a quick ratio of 1.97 and a current ratio of 2.40. The stock has a market cap of $115.41 million, a P\/E ratio of 204.00 and a beta of 1.87. The stocks fifty day moving average is $3.24 and its 200 day moving average is $3.37. <\/p>\n
Edap Tms (NASDAQ:EDAP) last posted its quarterly earnings results on Wednesday, August 28th. The medical equipment provider reported $0.05 earnings per share (EPS) for the quarter, topping the Thomson Reuters consensus estimate of $0.01 by $0.04. Edap Tms had a net margin of 4.57% and a return on equity of 23.31%. The firm had revenue of $14.04 million during the quarter, compared to analyst estimates of $11.92 million. On average, equities research analysts predict that Edap Tms will post 0.18 EPS for the current year. <\/p>\n
Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. Fosun International Ltd grew its stake in shares of Edap Tms by 9.4% during the second quarter. Fosun International Ltd now owns 397,568 shares of the medical equipment providers stock valued at $1,145,000 after purchasing an additional 34,083 shares during the last quarter. Morgan Stanley boosted its stake in Edap Tms by 222.7% in the second quarter. Morgan Stanley now owns 267,408 shares of the medical equipment providers stock valued at $722,000 after acquiring an additional 184,539 shares during the last quarter. Acadian Asset Management LLC bought a new position in Edap Tms in the second quarter valued at approximately $607,000. Susquehanna International Group LLP boosted its stake in Edap Tms by 762.9% in the second quarter. Susquehanna International Group LLP now owns 205,178 shares of the medical equipment providers stock valued at $556,000 after acquiring an additional 181,401 shares during the last quarter. Finally, JPMorgan Chase & Co. bought a new position in Edap Tms in the second quarter valued at approximately $282,000. 13.24% of the stock is currently owned by institutional investors and hedge funds. <\/p>\n
Edap Tms Company Profile<\/p>\n
EDAP TMS SA, together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally-invasive medical devices for the treatment of urological diseases worldwide. The company operates in two divisions: High Intensity Focused Ultrasound (HIFU), and Urology Devices and Services (UDS).<\/p>\n
Featured Story: Cryptocurrencies<\/p>\n
To view ValuEngines full report, visit ValuEngines official website.<\/p>\n
Receive News & Ratings for Edap Tms Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Edap Tms and related companies with MarketBeat.com's FREE daily email newsletter.<\/p>\n
<\/p>\n
See the original post here: <\/p>\n
Edap Tms (NASDAQ:EDAP) Downgraded to Hold at ValuEngine - TechNewsObserver<\/a><\/p>\n","protected":false},"excerpt":{"rendered":" ValuEngine lowered shares of Edap Tms (NASDAQ:EDAP) from a buy rating to a hold rating in a research report released on Saturday, August 31st, ValuEngine reports. Other research analysts have also issued research reports about the stock. Continue reading